Plotkin's Vaccines
- 9th Edition - February 1, 2028
- Latest edition
- Editors: Walter A. Orenstein, Paul A. Offit, Kathryn M. Edwards, Stanley A. Plotkin, Andrew J. Pollard
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 3 8 1 2 4 - 9
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 8 1 2 5 - 6
Plotkin's Vaccines stands as an authoritative and indispensable reference in the rapidly evolving field of immunization. Edited by world-renowned experts, this text has earned high… Read more
Purchase options
Plotkin's Vaccines stands as an authoritative and indispensable reference in the rapidly evolving field of immunization. Edited by world-renowned experts, this text has earned high praise from Bill Gates, who called it "an indispensable guide to the enhancement of the well-being of our world." Recognized with the BMA Award in the Public Health Category in 2018, this comprehensive resource delves into every facet of vaccination. This classic text covers the latest evidence, recommendations, and protocols, from groundbreaking vaccine development to their critical role in disease reduction. Recent advancements are highlighted in areas such as chikungunya and other alphaviruses, diarrhoeal vaccines, cancer vaccines, salmonella, respiratory syncytial virus, gonorrhea, and COVID-19. Vaccines remain one of the most effective and cost-efficient preventive measures, universally recommended for all children and, in many cases, adults. The newly revised and updated edition of Vaccines delivers the most authoritative information on vaccine production, available preparations, efficacy, and safety. It offers detailed recommendations for vaccine use, supported by data on the impact of vaccination programs on morbidity and mortality. The text provides comprehensive coverage of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology, public health, and regulatory issues. Each vaccine is thoroughly updated regarding its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, co-administration with other vaccines, and disease-control strategies. Plotkin's Vaccines is an essential resource for healthcare professionals, policymakers, and anyone committed to advancing public health through immunization.
Infectious diseases; immunology; vaccinology
Section I: General Aspects of Vaccination 1. A Short History of Vaccination 2. Vaccine Immunology 3. Non-Specific Effects of Vaccines 4. Correlates of Protection 5. The Vaccine industry 6. Vaccine Manufacturing 7. Evolution of Adjuvants Across the Centuries 8. Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States 9. Passive Immunization Section II: Licenced Vaccines and Vaccines in Development 10. General Immunization Practices 11. Adenovirus Vaccines 12. Anthrax Vaccines 13. Emerging Diseases and Emerging Vaccines (Military) 14. Cancer Vaccines 15. Chikungunya Vaccines 16. Cholera Vaccines 17. Combination Vaccines 18. Coronavirus Vaccines 19. Cytomegalovirus Vaccines 20. Dengue Vaccines 21. Diarrhea Caused by Bacteria 22. Diphtheria toxoid 23. Ebola Vaccines 24. Nonpolio Enterovirus Vaccines 25. Epstein-Barr Virus Vaccines 26. Haemophilus influenzae Type B Vaccines 27. Hepatitis A Vaccines 28. Hepatitis B Vaccines 29. Hepatitis C Vaccines 30. Hepatitis E Vaccine 31. Herpes Simplex Virus Vaccines 32. Human Immunodeficiency Virus Vaccines 33. Human Papillomavirus Vaccines 34. Inactivated influenza Vaccines 35. Influenza Vaccine—Live 36. Japanese Encephalitis Vaccines 37. Lyme Disease Vaccines 38. Malaria Vaccines 39. Measles Vaccines 40. Meningococcal Capsular A, B, C, W, and Y Conjugate Vaccines 41. Meningococcal Capsular B Vaccines 42. Mpox Vaccines 43. Mumps Vaccines 44. Noninfectious Disease Vaccines 45. Norovirus 46. Parasitic Disease Vaccines 47. Pertussis Vaccines 48. Plague Vaccines 49. Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines 50. Pneumococcal Polysaccharide Vaccines 51. Poliovirus Vaccine—inactivated 52. Poliovirus Vaccine—Live 53. Rabies Vaccines 54. Respiratory Syncytial Virus Vaccines 55. Rotavirus Vaccines 56. Rubella Vaccine 57. Smallpox and Vaccinia 58. Staphylococcus Aureus Vaccines 59. Streptococcus Group A Vaccines 60. Streptococcus Group B Vaccines 61. Tetanus toxoid 62. Tick-Borne Encephalitis Virus Vaccines 63. Tuberculosis Vaccines 64. Typhoid and Paratyphoid Vaccines 65. Varicella Vaccine 66. Yellow Fever Vaccine 67. Zika Vaccine 68. Zoster Vaccine Section III: New Technologies 69. Technologies for Making New Vaccines 70. The Development of Gene-Based Vectors for Immunization 71. Technologies to Improve Immunization Section IV: Vaccination of Special Groups 72. Vaccination of Immunocompromised Hosts 73. Vaccines for international Travel 74. Vaccines for Health Care Personnel 75. Vaccination of Pregnant Women Section V: Public Health and Regulatory Issues 76. Immunization in the United States 77. Immunization in Europe 78. Immunization in the Asia-Pacific Region 79. Immunization in Developing Countries 80. Community Protection 81. Economic Analyses of Vaccine Policies 82. Regulation and Testing of Vaccines in the US 83. Regulation of Vaccines in Europe 84. Regulation of Vaccines in Low and Middle-income Countries 85. Vaccine Safety 86. Vaccine Hesitancy 87. Legal Issues 88. Ethics Appendix: Websites and Applications for Mobile Devices With Information About Immunization
- Edition: 9
- Latest edition
- Published: February 1, 2028
- Language: English
WO
Walter A. Orenstein
Affiliations and expertise
Professor of Medicine and Pediatrics, and Global Health, Emory University; Associate Director, Emory Vaccine Center, Atlanta GA; Bill & Melinda Gates Foundation, Seattle, WA; Former Director, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, USAPO
Paul A. Offit
Affiliations and expertise
Chief, Division of Infectious Diseases, Director, Vaccine Education Center, The Children's Hospital of Philadelphia; Professor of Pediatrics, Maurice R. Hilleman Professor of Vaccinology, Perelman School of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USAKE
Kathryn M. Edwards
Affiliations and expertise
Professor of Pediatrics Emerita, USASP
Stanley A. Plotkin
Affiliations and expertise
Emeritus Professor of Pediatrics, University of Pennsylvania, Emeritus Professor, Wistar Institute, Former Chief, Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, PA; Former Medical and Scientific Director, Pasteur Merieux Connaught (now Sanofi Pasteur), Marnes-la-Coquette, FranceAP
Andrew J. Pollard
Sir Andrew is the Director of the Oxford Vaccine Group at the University of Oxford, a consultant paediatrician at Oxford Children’s Hospital, and a Fellow of St Cross College. He was knighted in 2021 for his contributions to public health during the pandemic and received the Order of Medical Merit from Brazil in 2022. He hosts "The Pandemic People" on the Oxford Colloquy Podcast.
Sir Andrew earned his medical degree from St Bartholomew’s Hospital Medical School in 1989 and a PhD from St Mary’s Hospital, London in 1999. His research focuses on immunity and vaccination against serious childhood infections. He led the clinical trials for the Oxford-AstraZeneca COVID-19 vaccine, resulting in over 3 billion doses distributed globally.
He has supervised 50 PhD students, published over 700 works, and received numerous awards, including the James Spence Medal in 2022. He chairs the UK Joint Committee on Vaccination and Immunisation and is involved with several prestigious organizations and trusts.
Affiliations and expertise
Ashall Professor of Infection & Immunity, Director of the Oxford Vaccine Group, Department of Paediatrics, Oxford Children’s Hospital